Skip to Content
Merck
CN
  • Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.

Influence of sub-inhibitory antibiotics and flow condition on Staphylococcus aureus ATCC 6538 biofilm development and biofilm growth rate: BioTimer assay as a study model.

The Journal of antibiotics (2014-05-29)
Francesca Berlutti, Alessandra Frioni, Tiziana Natalizi, Fabrizio Pantanella, Piera Valenti
ABSTRACT

Staphylococcus biofilm exhibits high antibiotic resistance and therapeutic doses of antibiotics are often sub-inhibitory. Whereas data are available on the effect of sub-inhibitory antibiotics on matrix formation, little is known on their influence on biofilm population. Here, using BioTimer Assay (BTA), a method developed to quantify biofilm population, the influence of sub-inhibitory gentamicin, ofloxacin and azithromycin on Staphylococcus aureus ATCC 6538 biofilm population in flow with respect to static condition was assessed. Antibiotics and flow condition increased biofilm population even if at different extent, depending on the antibiotic molecule. The greatest bacterial population was found in biofilm developed under flow condition in the presence of azithromycin. A significant increase in biofilm matrix was recorded for biofilm developed in the presence of antibiotics in flow with respect to static condition. The growth rates (GRs) of 24-h biofilm developed under the influence of antibiotics and flow condition were also evaluated using BTA and a specific mathematical model. Antibiotics and flow condition affected the GRs of 24-h biofilm even if at different extent. The lowest GR value was recorded for biofilm developed under flow condition in the presence of ofloxacin. Although further studies are needed, our data indicate that antibiotics and flow condition influenced biofilm development by increasing both bacterial population and matrix formation and affected the GRs of the developed biofilm. To the best of our knowledge, BTA is unique in allowing the calculation of the GRs of biofilm and it may be considered to be a useful study model to evaluate the activity of antibiofilm molecules.

MATERIALS
Product Number
Brand
Product Description

Azithromycin for peak identification, European Pharmacopoeia (EP) Reference Standard
Azithromycin for system suitability, European Pharmacopoeia (EP) Reference Standard
USP
Azithromycin Identity, United States Pharmacopeia (USP) Reference Standard
USP
Azithromycin, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
4,4,4-Trifluoro-1-phenyl-1,3-butanedione, 99%
Supelco
Ofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
Ofloxacin, fluoroquinolone antibiotic
Supelco
Ofloxacin, VETRANAL®, analytical standard
USP
Ofloxacin, United States Pharmacopeia (USP) Reference Standard
Ofloxacin, European Pharmacopoeia (EP) Reference Standard